When that vendor disappears, your research stops
This adjustment accounts for factors including: the pharmacy's order-processing time
ArdorComm Media News Network April 2, 2026 The Government of India has issued a comprehensive advisory on GLP-1 drugs, cautioning against their inappropriate use while acknowledging their growing role in managing type 2 diabetes and obesity
Outcomes In order to assess treatment effects on cardiovascular risk, the current analyses expanded upon the evaluation of changes in blood pressure and lipid parameters that have been previously reported [25, 26], and added evaluation of additional biomarkers of CV risk (ApoB, ApoC3, NT-pro-BNP, hsCRP and IL-6) in participants who received placebo, dulaglutide, or orforglipron during the T2D and obesity trials
Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J